logo
Trump's new trade tariff will have an impact not just on India but also South Asia. Here's how

Trump's new trade tariff will have an impact not just on India but also South Asia. Here's how

The Print4 days ago
The Trump administration has cited India's growing trade surplus with the US, which currently stands at 44.4 billion dollars, its tight energy and defence ties with Russia and Iran, and its active role in the BRICS (Brazil, Russia, India, China and South Africa) bloc as grounds for the tariff hike.
Under the new regime, US has imposed 25 percent tariff on Indian goods entering the nation.
New Delhi: Home to the world's largest textile manufacturing and electronics hubs, South Asia will see a significant impact from US President Donald Trump's sweeping trade overhaul which saw him sign an executive order imposing new tariffs on 69 countries.
In contrast, Pakistan emerged as an unexpected beneficiary under the new tariff regime. The US slashed tariffs on Pakistani imports from 29 percent to 19 percent and launched a new energy partnership with Islamabad aimed at tapping into the nation's domestic oil reserves.
In a Friday interview with Fox Radio, Secretary of State Marco Rubio reaffirmed that India is a key ally and strategic partner for the US but said India's energy ties with Russia are 'most certainly a point of irritation'.
While the 25 percent tariff raises India's export costs compared to peers like Vietnam and Bangladesh, India will likely remain a preferred country for manufacturing. This is because 33 percent of companies with global supply chains are reported to have moved their manufacturing activities out of China.
A report in Reuters also noted that India may remain attractive for global firms like Apple despite the tariff setback. It added that unlike other world leaders, Prime Minister Narendra Modi didn't secure a reduced tariff rate from the US, likely due to refusal to open India's sensitive agriculture and dairy sector to US goods, avoiding domestic backlash.
Speaking to ThePrint, Ajay Srivastava, former director general of Foreign Trade and current head of the Global Trade Research Initiative (GTRI), said India-US trade relations have entered turbulent waters but Trump's executive order mentions that tariffs may be reduced once countries do a deal with the US.
'The US has imposed new tariffs on imports from various countries, with rates ranging from 10 percent to 41 percent. These will be over and above the standard MFN tariffs. This means that imports from these countries will now face both the standard US tariff and an additional reciprocal tariff, raising overall duties significantly. Tariffs on China not announced and they will continue to be 30 percent,' he said.
Also Read: Modi's 'Make in India'—a case study in what happens when strategy is replaced by storytelling
Ripples in South Asia
Other South Asian economies have not been spared under the new US tariff regime.
Bangladesh and Sri Lanka now face 20 percent tariffs, levels that could erode their competitiveness in the US garments market, where price sensitivity is paramount. Afghanistan will see 15 percent duties, while Nepal, not explicitly listed, is expected to fall under a general 10 percent tariff.
For Sri Lanka, where garment exports make up over 40 percent of export revenue, the implications are stark. Many manufacturers are already using the impending hike as justification to freeze wages or lay off staff. Ranil Wickremesinghe, the former president, has warned that over 100,000 jobs could be at risk, The Economist reported.
The effects won't be limited to factory floors. We're talking about 2.5 to 6 million people who depend on these wages, Anton Marcus, a trade union leader in Colombo, was quoted as saying.
Bangladesh, already reeling from political upheaval after the 2024 ouster of Sheikh Hasina, is the world's second-largest exporter of ready-made garments, and saw major US buyers like Walmart and American Eagle suspending orders, citing uncertainty.
'We have lost nearly 25 percent of our US sales since March,' Mohiuddin Rubel, a former director of Bangladesh's garment manufacturers' and exporters' association told The Economist.
Bangladesh is ramping up imports from America to convince the Trump administration that it can close its $6 billion trade deficit. Recently, the government ordered 25 Boeing aircraft as well, it added.
Mohammad Yunus, the interim leader of Bangladesh, Friday welcomed the reduced tariffs.
'By reducing the tariff to 20 percent, 17 points lower than anticipated, our negotiators have demonstrated remarkable strategic skill and unwavering commitment to safeguarding and advancing Bangladesh's economic interests,' he wrote on X.
While the Pakistani government too celebrated the tariff reduction and energy partnership as a major diplomatic win, many in the country remain cautious.
'A 10-percentage-point cut may not be enough to prevent manufacturing from shifting to countries with even lower or zero tariffs, such as Egypt and Mexico. India, despite facing steep duties, continues to benefit from cost efficiencies in scale, infrastructure, and electricity, factors that could still make it more attractive to American buyers focused on maximising margins,' a Karachi-based economist told ThePrint.
Trump's executive order also targets several Southeast Asian nations suspected of enabling transshipment of Chinese goods.
Laos and Myanmar now face steep 40 percent tariffs, while Indonesia, Malaysia and the Philippines are subject to 19 percent (pls check figure). The move signals that Washington is widening its trade scrutiny in a bid to enforce a hard line on Chinese supply chains.
Impact on India
India's $86.5 billion in exports to the US, its largest single-country trading partner, could be significantly impacted.
The 25 percent duty is layered atop existing sector-specific US duties, including 50 percent on steel and aluminium, and 25 percent on vehicles and auto parts.
The US is India's largest market for textiles and apparel, accounting for nearly 28 percent of total exports in this segment. Indian textiles, currently facing 6-9 percent tariff, will be subject to a total duty of 31-34 percent after the additional 25 percent is applied.
Similarly, gems, jewellery and telecom products could see effective tariff rates ranging from 30-38.5 percent.
Pharmaceuticals have so far been excluded from the 25 percent tariffs imposed by the US.
The US has justified the higher tariff by pointing to India's high import duties, restricted market access and a $44.4 billion trade surplus enjoyed by India in FY25.
(Edited by Nida Fatima Siddiqui)
Also Read: India must not retaliate to Trump's tariff tactic. Secure interim deal, fix internal issues
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO
Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO

Economic Times

time3 minutes ago

  • Economic Times

Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO

Mr. Krishnakumar Vaidyanathan, Executive Director & Chief Operating Officer Eris Lifesciences looks to leverage its experience in integrated diabetes portfolio to take a lead among the first wave of generic semaglutide anti-diabetic and weight-loss drugs to hit the market early next year, a top official said. The company is looking at a 'good' share of the market, Krishnakumar Vaidyanathan, executive director and chief operating officer of Eris Lifesciences, told ET in an interaction. Semaglutide is the active ingredient in Novo Nordisk's blockbuster drugs Wegovy and Ozempic. Its patent in India will expire in March 2026. 'We are gearing up to be among the first to enter the market post loss of exclusivity,' Vaidyanathan said. 'We expect the overall market for GLP-1 at the end of the first 12 months (after the loss of exclusivity) to be at least 10 million units… And we expect to get a good share of the market.' Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Eris Lifesciences' existing diabetes portfolio includes orals, insulin and GLP-1 in the form of liraglutide. Its network of field representatives, patient connect and service platform in this space gives the firm an advantage over others, Vaidyanathan said. 'We do this day in and day out because of insulin. That gives us the confidence that we'll be able to step this up for GLP-1 as well.'Globally, the GLP-1 market is dominated by Eli Lilly and Novo Nordisk, which are also the two biggest insulin companies in the world. 'Being successful and big in the insulin market provides a huge tailwind when it comes to selling GLPs,' Vaidyanathan said. 'We have combined service with technology and product to create a winning combination in insulin and GLP therapy entry is not any different, which also requires a lot of patient education over and above the service on using the pens,' he said. 'We have an integrated diabetes portfolio because we currently sell GLP-1 in the form of liraglutide.' Dr Reddy's Labs, Sun Pharmaceutical Industries, Cipla, Mankind Pharma, Torrent Pharmaceuticals, and Zydus Lifesciences are also among Indian drugmakers readying to launch generic semaglutide next year. Eris Lifesciences launched liraglutide, a once-a-week GLP-1 product, last September. 'We have taken very good market shares in all the other LOE (loss of exclusivity) opportunities that we have seen in diabetes,' Vaidyanathan said. 'We have taken market ranks of 1 to 5 in each one without exception – vildagliptin, sitagliptin, linagliptin, dapagliflozin and empagliflozin. That gives us the confidence that we should be getting a fair share of the market.' Vishal Manchanda, pharma analyst at brokerage Systematix Group, said its full portfolio of anti-diabetes drugs to offer to diabetologist, spanning all oral and injectable options, should give Eris Lifesciences 'a strong positioning in a market where the large pharma majors like Sun, Lupin, Dr Reddy's, Cipla, Mankind and Zydus come in with their dominant brand presence.'

Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead
Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead

Hans India

time6 minutes ago

  • Hans India

Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead

New Delhi: Major global and Indian brokerages remain optimistic on Vedanta Ltd's performance for FY26, citing stronger LME pricing trends, cost discipline, deleveraging, and a resilient aluminium business among the key growth drivers. These firms have also taken note of the several growth projects scheduled for commissioning or completion in the next few quarters. JP Morgan noted that Vedanta's first quarter consolidated EBITDA was largely in line with estimates, with key segments such as aluminium, oil and gas, and power faring better than its expectations, leading to an overall segmental EBITDA beat. On the earnings trajectory for the current and next fiscal, the firm expects various ongoing initiatives at Vedanta to aid growth. "Vedanta's capacity expansion journey in the aluminium business as well as vertical integration should bring cost advantages. LME prices have also bottomed out and should continue to move higher into FY26-27, likely aiding earnings growth." Echoing similar views on LME prices and its potential benefit, Citi Research cited that Vedanta's parent (Vedanta Resources) leverage is at comfortable levels. It listed potential upside in medium-term aluminium LME prices, lower cost, and the demerger as another positive for Vedanta, while adding that aluminium globally has a limited supply growth. Mumbai-based Nuvama Institutional Equities expects Vedanta to deliver quarter-on-quarter EBITDA growth in Q2. "Q2FY26 EBITDA is likely to increase 10 per cent-plus quarter-on-quarter on the back of higher prices and lower aluminium cost of production. Major aluminium projects are likely to be commissioned in Q2FY26. We reckon net debt/EBITDA ex-Hindustan Zinc shall fall to 1.7x by FY26-end, compared to 2.7x in FY25. Demerger of the business is likely to be concluded in Q4FY26," the firm said in its report. The brokerage expects Vedanta's all major projects except coal blocks to be likely commissioned in the current fiscal, providing volume growth and cost reduction visibility for the company. UK-based Investec stated in its post-earnings report that Vedanta is a key beneficiary of depreciation in the Indian Rupee. Other near-term positives listed by the firm include declining alumina prices and the company offering attractive yields. The firm has retained its buy recommendation on Vedanta. Research firms like Kotak Institutional Equities and IIFL have cited factors like cost efficiencies and deleveraging at both Vedanta Ltd and its parent Vedanta Resources as beneficial factors. Vedanta's adjusted profit after tax jumped 13 per cent year-on-year to Rs 5,000 crore. The company clocked its highest-ever first-quarter EBITDA of Rs 10,746 crore, which was up 5 per cent year-on-year.

SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya
SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya

The Hindu

time6 minutes ago

  • The Hindu

SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya

Describing the Special Intensive Revision (SIR) drive under way in Bihar as 'an invasive reconstruction of the electoral roll,' Dipankar Bhattacharya, general secretary of the Communist Party of India (Marxist-Leninist) Liberation, said States including Kerala should be on guard as it could be applied in other parts of the country as well. 'If they get away with it in Bihar, they will apply it everywhere,' he said, delivering the 24th memorial lecture in memory of the journalist N. Narendran on the topic 'Bihar: Trial run for Mass Disenfranchisement.' 'In fact, some people in Kerala and Tamil Nadu may still be believing that, well, this is something only happening in north India. If it is happening in north India, it is only a matter of time it happens here. No part of India is secure. Every State, every community, every political geography, every social equation, is vulnerable,' he said. The concept of citizenship as Indians have known it no longer remains valid as people will now be forced to prove their citizenship. The migrant workers of Bihar have emerged as one of the most vulnerable sections of electors in the SIR in Bihar, given the Election Commission of India's definition of 'ordinary resident.' This could have implications for Kerala as well, which has a large migrant population, he said. The SIR in Bihar, he said, was not just about rewriting the electoral roll, but it was about rewriting the electoral rules, he said. 'By rewriting the electoral rules, you are rewriting the entire grammar of elections in India,' he said. Mr. Dipankar Bhattacharya said that the INDIA Bloc was the need of the hour, observing that the BJP has grown at the expense of all other parties. 'If we cannot identify who the common enemy is, we will be doing so at our own peril,' he said. He underscored the need for a broad-based, sustained and multi-pronged resistance against what he described as the 'fascist offensive' of the BJP-RSS in the country. On the BJP's 'One Nation, One Election' proposal, Mr. Bhattacharya said it holds grave implications for the concepts of democracy and federalism. 'Every election has its own context. A Lok Sabha election has its own context, an Assembly election has its own context, a panchayat election will have its own context. If you bulldoze, flatten everything into one single narrative, and one single context for the whole elections, there will be nothing left of India's federalism and democracy as we have known it all these years,' he said, adding that the current challenges facing the Indian people is unlike any other in the post-Independence era.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store